13.05.2026
Biovac's expansion funding in Africa hits $128m after a $20m French finance commitment, with the full $180m target due by the end of May.
21.04.2026
Biovac secures major funding for African vaccine manufacturing. The expansion is supported with funds from the EIB and IFC.
07.02.2026
South Africa launches the HIV vaccine trial, BRILLIANT 01, testing a new vaccine cocktail designed to prime broadly neutralising antibodies.
10.11.2025
Biovac R&D Lab opens in Cape Town, enhancing vaccine manufacturing capabilities for Africa with support from the Gates Foundation.
29.07.2025
Learn about Cape Town's innovative research in traumatic child brain injury and its potential global impact on treatment.
29.06.2025
Biovac secures a deal with Biological E to produce a pneumonia vaccine in Africa, promoting vaccine independence continent-wide.